n(6)-carboxymethyllysine has been researched along with Atrial Fibrillation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Begieneman, MP; Krijnen, PA; Kubat, B; Niessen, HW; Paulus, WJ; Rijvers, L; Schalkwijk, CG; Stooker, W; van Rossum, AC; Vonk, AB | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and Atrial Fibrillation
Article | Year |
---|---|
Atrial fibrillation coincides with the advanced glycation end product N(ε)-(carboxymethyl)lysine in the atrium.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Fibrosis; Granulocytes; Heart Atria; Humans; Lymphocytes; Lysine; Macrophages; Male; Middle Aged; Myocardium; Vascular Cell Adhesion Molecule-1 | 2015 |